114 related articles for article (PubMed ID: 32867456)
1. [KDM6A mutation and expression in gastric cancer are associated with prognosis].
Li LL; Huang ZG; Wang YW; Lu M; Hu KW
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):648-652. PubMed ID: 32867456
[No Abstract] [Full Text] [Related]
2. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
Lee SW; Park DY; Kim MY; Kang C
Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
[TBL] [Abstract][Full Text] [Related]
3. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
4. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
5. Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer.
Chen X; Yang Z; Feng J; Duan T; Pan T; Yan L; Jin T; Xiang Y; Zhang M; Chen P; Wang W; Zhang R; Chen B; Zhao L; Xie T; Sui X
Cancer Med; 2021 Jan; 10(1):317-324. PubMed ID: 33174323
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
[No Abstract] [Full Text] [Related]
7. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic characteristics and prognostic factors of gastric cancer in the elderly patients over 75 years].
Gao H; Lan X; Li S; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):522-5. PubMed ID: 27215518
[TBL] [Abstract][Full Text] [Related]
10. Significance of KDM6A mutation in bladder cancer immune escape.
Chen X; Lin X; Pang G; Deng J; Xie Q; Zhang Z
BMC Cancer; 2021 May; 21(1):635. PubMed ID: 34051747
[TBL] [Abstract][Full Text] [Related]
11. Significance of aquaporins' expression in the prognosis of gastric cancer.
Thapa S; Chetry M; Huang K; Peng Y; Wang J; Wang J; Zhou Y; Shen Y; Xue Y; Ji K
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29678898
[TBL] [Abstract][Full Text] [Related]
12. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
15. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
Cheng G; Li M; Wu J; Ji M; Fang C; Shi H; Zhu D; Chen L; Zhao J; Shi L; Xu B; Zheng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9452-7. PubMed ID: 26464703
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between body mass index and clinicopathological characteristics and prognosis of gastric cancer patients].
Han BL; Wang YM; Xue YW
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):527-532. PubMed ID: 31357840
[No Abstract] [Full Text] [Related]
17. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
18. [Discovery and verification of matrix gla protein, a TNM staging and prognosis-related biomarker for gastric cancer].
Guo L; Guo XB; Jiang JL; Zhang JN; Ji J; Liu BY; Zhu ZG; Yu YY
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):436-41. PubMed ID: 21055170
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Liu J; Liu Z; Zhang X; Gong T; Yao D
BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
[TBL] [Abstract][Full Text] [Related]
20. [Value of tumor deposits in staging and prognostic evaluation in gastric cancer patients].
Liang W; Zhou Z; Cui J; Xi H; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):277-282. PubMed ID: 28338160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]